title: Epidemiology and treatment of mucormycosis.
abstract: Mucormycosis is an uncommon but aggressive opportunistic fungal infection that afflicts patients with severe underlying immunosuppression, uncontrolled hyperglycemia and/or ketoacidosis, patients with iron overload resulting from frequent blood transfusions or blood disorders and occasionally healthy patients who are inoculated with fungal spores through traumatic injuries. The clinical presentation of mucormycosis is initially indistinguishable from other common infections, and if not diagnosed early and aggressively treated, it is almost always fatal. In this article we summarize recent changes in the epidemiology of mucormycosis, discuss diagnostic and clinical clues suggestive of the infection and provide a general strategy for managing the infection in the absence of data from well-controlled, prospective clinical trials.
authors.affiliation: Clinic of Infectious Diseases, Department of Internal Medicine, Geriatrics & Nephrologic Diseases, S'Orsola Malpighi Hospital, University of Bologna, Bologna, Italy.
authors.forename: Russell E
authors.initials: RE
authors.lastname: Lewis
authors.forename: Dimitrios P
authors.initials: DP
authors.lastname: Kontoyiannis
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy / Q000379:methods; D003955:Diagnostic Tests, Routine; D006801:Humans; D009090:Mucorales / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D009091:Mucormycosis / Q000175:diagnosis / Q000453:epidemiology* / Q000473:pathology / Q000628:therapy; D013514:Surgical Procedures, Operative / Q000379:methods
chemical_list: D000935:Antifungal Agents